Susquehanna Fundamental Investments, LLC Liminal Bio Sciences Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.92 - $2.2 $10,826 - $25,889	-11,768 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.92 $21,138 - $38,541	-9,832 Reduced 45.52%	11,768 $27,000
Q2 2021 Aug 11, 2021	SELL	$3.75 - $5.17 $44,250 - $61,006	-11,800 Reduced 35.33%	21,600 $84,000
Q1 2021 May 17, 2021	SELL	$3.94 - $6.43 $137,959 - $225,146	-35,015 Reduced 51.18%	33,400 $138,000
Q4 2020 Feb 16, 2021	BUY	$3.68 - $11.02 $251,767 - $753,933	68,415 New	68,415 $287,000

234

Ticker LMNL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,042,600
Description
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.